Trial Profile
A Single-Dose, Dose-Escalation Study to Determine the Safety, Tolerability, and Pharmacokinetics of LY3025876 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jul 2018
Price :
$35
*
At a glance
- Drugs LY 3025876 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Eli Lilly and Company
- 10 Jun 2013 New trial record